Procedures Point at Forms That Were Retired Years Ago
Fifteen years of revisions by different authors in different templates. The content is usually right; the cross-references are the thing that fails an inspection.
Pharmaceutical
The industry where the procedure is the product. A batch that was made correctly and documented badly is a batch that was made badly, and every regulator on earth agrees on that point.
FDA · United States
ICH · International
EU · GMP
The Shape of It
Most of the recoverable cost here sits in the SOP estate: procedures written by different people over fifteen years, in four formats, cross-referencing versions that no longer exist. That is a quality problem before it is a writing problem, and it is the one QES is most often brought in to solve.
The second is calibration and equipment. Traceability to a national standard is easy to assert and surprisingly hard to evidence in one place — which is exactly what an inspector asks for.
What Applies
10 Documents an Auditor Is Likely to Open
The working set, not an exhaustive register. Each row prints the body that issues it, so nothing here depends on the color of the rule beside it. Customer-specific requirements sit on top of all of it and are frequently where the real work is.
FDA · US
21 CFR 210 / 211
cGMP for Finished Pharmaceuticals. The master and batch records, and everything that has to reconcile back to them.
FDA · US
21 CFR 11
Electronic Records and Signatures. Audit trails, system validation, and who is permitted to change what.
FDA · US
21 CFR 4
Combination Products. Where the device and the drug systems have to be reconciled rather than run in parallel.
FDA · US
21 CFR 314
Applications. What the submission commits you to, and therefore what a change has to be assessed against.
ICH · Intl
ICH Q7
GMP for Active Pharmaceutical Ingredients. The upstream half that most finished-dose firms audit rather than operate.
ICH · Intl
ICH Q9
Quality Risk Management. The pharmaceutical counterpart to ISO 14971, and increasingly read alongside it.
ICH · Intl
ICH Q10
Pharmaceutical Quality System. Management review, CAPA, change management, and continual improvement as one system.
EU · GMP
EU GMP Annex 1
Sterile Medicinal Products. The revised edition, published August 25, 2022, has applied since August 25, 2023.
EU · GMP
EU GMP Annex 11
Computerised Systems. The European answer to Part 11, and not identical to it. A full revision has been out for consultation since July 2025; the 2011 text remains in force.
NIST · US
NIST Traceability
Calibration. An unbroken chain from the instrument on the floor to a national standard, written down.
Every standard above has a page and a free brief on QES letterhead, with its status as checked on October 24, 2026. Browse Standards & Guidance.
In Practice
Three Things That Usually Go Wrong Here
Not statistics — QES's own reading of where these systems are most often found short, from thirty years of building and auditing them.
Calibration Is Traceable but Not Evidenced
The certificates exist, somewhere. The unbroken chain from the instrument on the floor to a national standard has never been written down in one document.
Training Records Prove Attendance, Not Competence
A signature on a sign-in sheet is not evidence that the operator can perform the procedure. The distinction matters the first time a deviation is investigated.
A Real-World Case
Artificial Tears That Were Not Sterile
A 2023 outbreak traced to imported over-the-counter eye drops shows why sterility assurance is part of the product, not a test at the end of it.
81patients in 18 states, per CDC as of May 15, 2023
- What Happened
- CDC linked an outbreak of extensively drug-resistant Pseudomonas aeruginosa to artificial tears, with specimens collected from May 2022 to April 2023. On February 2, 2023, the manufacturer, Global Pharma of Chennai, India, voluntarily recalled EzriCare Artificial Tears, Delsam Pharma Artificial Tears, and Delsam Pharma Artificial Ointment.
- What the Investigation Found
- FDA testing of unopened bottles of EzriCare Artificial Tears identified bacterial contamination. CDC laboratory testing found the outbreak strain in opened bottles from multiple lots.
- What It Cost
- Among patients with clinical cultures, CDC reported 14 with vision loss, 4 more who had an eye surgically removed, and 4 deaths within 30 days of culture collection.
Sources. CDC — Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears (archived page, reviewed May 18, 2023) (opens in a new tab). A public case, summarized from the official findings and reporting cited; QES was not involved in it. Figures are quoted as published. Checked October 24, 2026.
Where to Start
Against the Clause, Not Against a Feeling
A fixed-price gap assessment — two days on your floor and in your files, from $4,800 — produces a clause-by-clause table: what you have, what the standard in your column actually requires, what is missing, and what has to be written — with an owner and a date against each line. You keep the findings whether or not you engage further.
On This Page. The standards listed are the working set an auditor is most likely to open, not an exhaustive register. Dated statements are sourced on the research page. The experience described is drawn from Marcia Weeden's employment record and is available in full on her résumé. Canceled military specifications are marked as canceled where they are still cited in contract flowdowns. Checked October 24, 2026.